Screener
Asset Entities ASST Medical Device — Other investment loss
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Asset Entities in its filing.
Tagged under the XBRL concept us-gaap:UnrealizedGainLossOnInvestments.
The source filing: Asset Entities’s 10-Q, filed August 10, 2026.
- Filed
- Aug 10, 2026, 7:01 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054985
| Line item | Successor / Three Months Ended June 30, 2026 | Predecessor / Three Months Ended June 30, 2025 |
|---|---|---|
| Investment losses: | ||
| Net unrealized loss on digital assets, at fair value | (228,031) | — |
| Net unrealized loss on investments in preferred equity, at fair value | (5,962) | — |
| Other investment loss | (2,801) | — |
| Total investment losses | (236,794) | — |
| Net operating loss | (258,249) | (3,690) |
| Other income/(expense): | ||
| Other income | 955 | 252 |
Item 1. Consolidated Financial Statements
FAQ
- What is Asset Entities's medical device — other investment loss?
- Asset Entities (ASST) reported medical device — other investment loss of $0 in Q2 2026.
- What does medical device — other investment loss mean?
- This metric represents the non-operating financial losses incurred from investments held within the medical device business segment. It captures impairments, write-downs, or realized losses on equity or debt instruments that are distinct from the segment's core operational activities. Monitoring this figure helps investors assess the impact of peripheral capital allocation decisions on the segment's overall profitability.
Ask your AI about Asset Entities's medical device — other investment loss.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude